Digital Health Intelligence Limited 31/03/2021 iXBRL

Digital Health Intelligence Limited 31/03/2021 iXBRL

DIGITAL HEALTH INTELLIGENCE LIMITED - Company Information

Print Friendly Version

31/03/2021 2021-03-31 false false false false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2020-04-01 Sage Accounts Production 21.0 - FRS102_2019 xbrli:pure xbrli:shares iso4217:GBP 09257440 2020-04-01 2021-03-31 09257440 2021-03-31 09257440 2020-03-31 09257440 2019-04-01 2020-03-31 09257440 2020-03-31 09257440 core:LandBuildings core:ShortLeaseholdAssets 2020-04-01 2021-03-31 09257440 core:PlantMachinery 2020-04-01 2021-03-31 09257440 core:FurnitureFittingsToolsEquipment 2020-04-01 2021-03-31 09257440 bus:OrdinaryShareClass1 2020-04-01 2021-03-31 09257440 bus:OrdinaryShareClass2 2020-04-01 2021-03-31 09257440 bus:OrdinaryShareClass3 2020-04-01 2021-03-31 09257440 bus:PreferenceShareClass1 2020-04-01 2021-03-31 09257440 bus:PreferenceShareClass2 2020-04-01 2021-03-31 09257440 bus:PreferenceShareClass3 2020-04-01 2021-03-31 09257440 bus:Director1 2020-04-01 2021-03-31 09257440 core:WithinOneYear 2021-03-31 09257440 core:WithinOneYear 2020-03-31 09257440 core:AfterOneYear 2021-03-31 09257440 core:ShareCapital 2021-03-31 09257440 core:ShareCapital 2020-03-31 09257440 core:RetainedEarningsAccumulatedLosses 2021-03-31 09257440 core:RetainedEarningsAccumulatedLosses 2020-03-31 09257440 bus:OrdinaryShareClass1 core:ShareCapital 2021-03-31 09257440 bus:OrdinaryShareClass1 core:ShareCapital 2020-03-31 09257440 bus:OrdinaryShareClass2 core:ShareCapital 2021-03-31 09257440 bus:OrdinaryShareClass2 core:ShareCapital 2020-03-31 09257440 bus:OrdinaryShareClass3 core:ShareCapital 2021-03-31 09257440 bus:OrdinaryShareClass3 core:ShareCapital 2020-03-31 09257440 bus:PreferenceShareClass1 core:ShareCapital 2021-03-31 09257440 bus:PreferenceShareClass1 core:ShareCapital 2020-03-31 09257440 bus:PreferenceShareClass2 core:ShareCapital 2021-03-31 09257440 bus:PreferenceShareClass2 core:ShareCapital 2020-03-31 09257440 bus:PreferenceShareClass3 core:ShareCapital 2021-03-31 09257440 bus:PreferenceShareClass3 core:ShareCapital 2020-03-31 09257440 bus:SmallEntities 2020-04-01 2021-03-31 09257440 bus:AuditExempt-NoAccountantsReport 2020-04-01 2021-03-31 09257440 bus:AbridgedAccounts 2020-04-01 2021-03-31 09257440 bus:SmallCompaniesRegimeForAccounts 2020-04-01 2021-03-31 09257440 bus:PrivateLimitedCompanyLtd 2020-04-01 2021-03-31
Company registration number: 09257440
Digital Health Intelligence Limited
Information for Filling with The Registrar
31 March 2021
Digital Health Intelligence Limited
Contents
Abridged statement of financial position
Notes to the financial statements
Digital Health Intelligence Limited
Abridged statement of financial position
31 March 2021
2021 2020
Note £ £ £ £
Fixed assets
Tangible assets 6 22,936 28,066
_______ _______
22,936 28,066
Current assets
Debtors 395,407 298,867
Cash at bank and in hand 1,589,207 1,014,584
_______ _______
1,984,614 1,313,451
Creditors: amounts falling due
within one year ( 1,412,374) ( 1,024,793)
_______ _______
Net current assets 572,240 288,658
_______ _______
Total assets less current liabilities 595,176 316,724
Creditors: amounts falling due
after more than one year ( 50,000) -
Provisions for liabilities ( 2,826) ( 3,587)
_______ _______
Net assets 542,350 313,137
_______ _______
Capital and reserves
Called up share capital 7 200 200
Profit and loss account 542,150 312,937
_______ _______
Shareholders funds 542,350 313,137
_______ _______
For the year ending 31 March 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the current year ending 31 March 2021 in accordance with Section 444(2A) of the Companies Act 2006.
These financial statements were approved by the board of directors and authorised for issue on 20 December 2021 , and are signed on behalf of the board by:
Mr J E Hoeksma
Director
Company registration number: 09257440
Digital Health Intelligence Limited
Notes to the financial statements
Year ended 31 March 2021
1. General information
The company is a private company limited by shares, registered in the UK. The address of the registered office is 7 Bell Yard, London, England, WC2A 2JR.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. The Triennial review 2017 amendments to the standard have been early adopted.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Leasehold properties - 4 % straight line
Plant and machinery - 25 % reducing balance
Computer equipment - 25 % reducing balance
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 21 (2020: 16 ).
5. Directors remuneration
Remuneration 209,028 187,674
Company contributions to pension schemes in respect of qualifying services 6,274 7,523
_______ | _______ |
195,197 166,799
_______ | _______ |
6. Tangible assets
£
Cost
At 1 April 2020 72,379
Additions 1,420
_______
At 31 March 2021 73,799
_______
Depreciation
At 1 April 2020 44,313
Charge for the year 6,550
_______
At 31 March 2021 50,863
_______
Carrying amount
At 31 March 2021 22,936
_______
At 31 March 2020 28,066
_______
7. Called up share capital
Issued, called up and fully paid
2021 2020
No £ No £
Amounts presented in equity:
Ordinary A shares of £ 0.01 each 9,500 95 9,500 95
Ordinary B shares of £ 0.01 each 9,500 95 9,500 95
Ordinary shares of £ 0.01 each 1,000 10 1,000 10
_______ _______ _______ _______
20,000 200 20,000 200
_______ _______ _______ _______
Amounts presented in liabilities:
Ordinary A shares of £ 0.01 each 9,500 95 9,500 95
Ordinary B shares of £ 0.01 each 9,500 95 9,500 95
Ordinary shares of £ 0.01 each 1,000 10 1,000 10
_______ _______ _______ _______
20,000 200 20,000 200
_______ _______ _______ _______
8. Related party transactions
At the end of the year the directors' current accounts amounted to £95,000 (2020 : £66,000) for Mr J E Hoeksma , Nil (2020 : Nil ) for Ms L M Davidson and Nil (2020 : Nil) for Mr M J F Hudson.
9. Controlling party
The ultimate controlling parties are Mr J E Hoeksma and Ms L M Davidson, who own 93% of the issued share capital of the company.